Neuropsychological predictors of transition from healthy cognitive aging to mild cognitive impairment: The PATH through life study

American Journal of Geriatric Psychiatry

Volumn 18, Issue 8, 2010, Pages 723-733

  Cherbuin, Nicolas ^a   Sachdev, Perminder ^b,c   Anstey, Kaarin J ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Neuropsychiat Inst   (Australia)

Author keywords

behavioral variability; cognition; Mild cognitive impairment; screening

Indexed keywords

ADULT; AGING; ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; DIGITS SPAN BACKWARD TEST; FEMALE; HUMAN; IMMEDIATE AND DELAYED RECALL TEST; MAJOR CLINICAL STUDY; MENTAL HEALTH; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; PREDICTION; PSYCHOLOGICAL RATING SCALE; RECALL; RESPONSE TIME; SIMPLE AND CHOICE REACTION TEST; SPOT THE WORD TEST; SYMBOL DIGITS MODALITIES TEST;

EID: 77955173642     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e3181cdecf1     Document Type: Article

References (40)

1. Petersen RC, Smith GE, Waring SC, et al: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56:303-308
2. Ravaglia G, Forti P, Maioli F, et al: Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors. Dement Geriatr Cogn Disord 2006; 21:51-58
3. Amieva H, Letenneur L, Dartigues JF, et al: Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study. Dement Geriatr Cogn Disord 2004; 18:87-93
4. Ashford JW: APOE genotype effects on Alzheimer's disease onset and epidemiology. J Mol Neurosci 2004; 23:157-165
5. Forsberg A, Engler H, Almkvist O, et al: PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging 2008; 29:1456-1465
6. Mosconi L, Mistur R, Switalski R, et al: FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease. Eur J Nucl Med Mol Imaging 2009; 36:811-822
7. Braak H, Alafuzoff I, Arzberger T, et al: Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol (Berl) 2006; 112:389-404
8. Ohm TG, Muller H, Braak H, et al: Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience 1995; 64:209-217
9. Salthouse TA: The processing-speed theory of adult age differences in cognition. Psychol Rev 1996; 103:403-428
10. Gordon B, Carson K: The basis for choice reaction time slowing in Alzheimer's disease. Brain Cogn 1990; 13:148-166
11. Boustani M, Peterson B, Hanson L, et al: Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 2003; 138:927-937
12. de Jager CA, Schrijnemaekers AC, Honey TE, et al: Detection of MCI in the clinic: evaluation of the sensitivity and specificity of a computerised test battery, the Hopkins Verbal Learning Test and the MMSE. Age Ageing 2009; 38:455-460
13. Hultsch DF, MacDonald SW, Hunter MA, et al: Intraindividual variability in cognitive performance in older adults: comparison of adults with mild dementia, adults with arthritis, and healthy adults. Neuropsychology 2000; 14:588-598
14. Lovden M, Li SC, Shing YL, et al: Within-person trial-to-trial variability precedes and predicts cognitive decline in old and very old age: longitudinal data from the Berlin Aging Study. Neuropsycho-logia 2007; 45:2827-2838
15. Murtha S, Cismaru R, Waechter R, et al: Increased variability accompanies frontal lobe damage in dementia. J Int Neuropsy-chol Soc 2002; 8:360-372
16. Bunce D, Anstey KJ, Christensen H, et al: White matter hyperin-tensities and within-person variability in community-dwelling adults aged 60-64 years. Neuropsychologia 2007; 45:2009-2015
17. Anstey KJ, Dear K, Christensen H, et al: Biomarkers, health, lifestyle, and demographic variables as correlates of reaction time performance in early, middle, and late adulthood. Q J Exp Psy-chol A 2005; 58:5-21
18. Cherbuin N, Reglade-Meslin C, Kumar R, et al: Risk factors of transition from normal cognition to mild cognitive disorder: the PATH through life study. Dement Geriatr Cogn Disord 2009;28: 47-55
19. Kumar R, Dear KB, Christensen H, et al: Prevalence of mild cognitive impairment in 60-to 64-year-old community-dwelling individuals: the personality and total health through life 60 + study. Dement Geriatr Cogn Disord 2005; 19:67-74
20. Morris JC: The clinical dementia rating (CDR): current version and scoring rules. Neurology 1993; 11:2412-2414
21. Reitan RM: Validity of the Trail Making Test as an indicator of organic brain syndrome. Percept Mot Skills 1958; 8:271-276
22. Borkowski J, Benton AL, Spreen O: Word fluency and brain damage. Neuropsychologia 1967; 5:135-140
23. Wolf-Klein GP, Silverstone FA, Levy AP, et al: Screening for Alzheimer's disease by clock drawing. J Am Geriatr Soc 1989; 37:730-734
24. Saxton J, Ratcliff G, Munro CA, et al: Normative data on the Boston Naming Test and two equivalent 30-item short forms. Clin Neuropsychol 2000; 14:526-534
25. Morris JC, HeymanA, MohsRC, etal: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989; 39:1159-1165
26. Lazak MD. Neuopsychological Assessment. Oxford, England, Oxford University Press, 1995
27. Kral VA: Senescent forgetfulness: benign and malignant. Can Med Assoc J 1962; 86:257-260
28. Crook T, Bartus R, Ferris SH, et al: Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change. Report of a National Institute of Mental Health Working Group. Dev Neuropsychol 1986; 2:261-276
29. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, DC, APA, 1994
30. Morris JC: The Clinical dementia rating (CDR): current version and scoring rules. Neurology 1993; 43:2412-2414
31. Anstey KJ, Cherbuin N, Christensen H, et al: Follow-up of mild cognitive impairment and related disorders over 4 years in adults in their sixties: the PATH through life study. Dement Geriatr Cogn Disord 2008; 26:226-233
32. Folstein MF, Folstein SE, McHugh PR: "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
33. Yuspeh RL, Vanderploeg RD: Spot-the-Word: a measure for estimating premorbid intellectual functioning. Arch Clin Neuropsy-chol 2000; 15:319-326
34. Fleisher AS, Sowell BB, Taylor C, et al. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology. 2007; 68:1588-1595
35. Christensen H, Dear KB, Anstey KJ, et al: Within-occasion intra-individual variability and preclinical diagnostic status: is intrain-dividual variability an indicator of mild cognitive impairment? Neuropsychology 2005; 19:309-317
36. Loewenstein DA, Acevedo A, Small BJ, et al: Stability of different subtypes of mild cognitive impairment among the elderly over a 2-to 3-year follow-up period. Dement Geriatr Cogn Disord 2009; 27:418-423
37. Saxton J, Snitz BE, Lopez OL, et al: Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia. J Neurol Neurosurg Psychiatry 2009; 80:737-743
38. Quadri P, Zanda E, Levorato A, et al: Severity of mild cognitive impairment is a predictor of conversion to dementia: The canton ticino study. Alzheimer Dement 2009; 5:P360-P360
39. Cherbuin N, Reglade-Meslin C, Kumar R, et al: Risk Factors of transition from normal cognition to mild cognitive disorder: the PATH through life study. Dement Geriatr Cogn Disord 2009; 28:47-55
40. Crowell TA, Vanderploeg RD, Small BJ, et al: Elderly norms for the Spot-the-Word test. Arch Clin Neuropsychol 2002; 17:123-130